Acute Coronary Syndromes, Third Edition

Front Cover
Eric J. Topol
CRC Press, Nov 8, 2000 - Medical - 880 pages
Reflecting rapid innovations in the field, Acute Coronary Syndromes, Second Edition uncovers the structural, physiological, and functional foundations of acute coronary syndromes-including the latest advances in the causes of inflammation and embolization, therapeutics, intravenous and oral antiplatelet agents, and anticoagulants.

Presents original theories in the cost-effectiveness of diagnostic therapies of acute coronary syndromes!

Providing seven new chapters demonstrating the most up-to-date information on invasive and conservative management strategies, aspirin resistance, and public health implications, Acute Coronary Syndromes, Second Edition
  • illustrates current approaches to bedside platelet function testing
  • considers novel ideas in combined fibrin and platelet-lysis for myocardial infarction
  • describes recent treatments with tirofiban, eptifibatide, clopidogrel, and low-molecular- weight heparins
  • and more!
    Written by over 40 international experts in the field, Acute Coronary Syndromes, Second Edition is a monumental reference for cardiologists; internists; epidemiologists; molecular and cell biologists; pharmacologists; emergency room personnel; and graduate and medical school students in these disciplines.
  •  

    What people are saying - Write a review

    We haven't found any reviews in the usual places.

    Contents

    Inflammation in Acute Coronary Syndromes
    1
    Vascular Biology of the Acute Coronary Syndromes
    33
    Pathological and Anatomical
    59
    Embolization as a Pathological Mechanism
    79
    Insights from Intravascular Ultrasound
    111
    Differences Between Unstable Angina and Acute
    135
    First
    215
    ThirdGeneration Thrombolytic Agents for Acute
    243
    Aspirin Ticlopidine
    453
    Aspirin Resistance
    499
    Antithrombin Therapy in Acute Coronary Syndromes
    515
    Bedside Anticoagulant Testing
    541
    Bedside Platelet Monitoring
    563
    Hypolipidemic Intervention and Plaque Stabilization
    599
    Pathobiology Diagnosis
    639
    Reperfusion Injury
    689

    Combination Fibrinolysis and Platelet IIbIIIa Antagonism
    271
    Diagnosis of Acute Coronary Syndromes in
    293
    The Role of the Troponins and Other Markers
    329
    Stenting in Acute Myocardial Infarction
    373
    Early Invasive Versus Early Conservative Strategies
    391
    Intravenous Glycoprotein IIbIIIa Receptor Inhibitor
    419
    Lessons from the GUSTO Trials
    725
    Quality of Coronary Disease Report Cards
    789
    CostEffectiveness of New Diagnostic Tools
    811
    Index
    845
    Copyright

    Common terms and phrases

    Popular passages

    Page 787 - The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial.

    Bibliographic information